Join
Live feed
·
SECFilingvia Quantisnow
Diffusion Pharmaceuticals Inc. logo

Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Leadership Update, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
DFFN· Diffusion Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DFFN (Diffusion Pharmaceuticals Inc.) and more on Quantisnow.

Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Leadership Update, Financial Statements and Exhibits | Quantisnow